Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Recombinant M2e protein-based ELISA: a novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones.

Hemmatzadeh F, Sumarningsih S, Tarigan S, Indriani R, Dharmayanti NL, Ebrahimie E, Igniatovic J.

PLoS One. 2013;8(2):e56801. doi: 10.1371/journal.pone.0056801. Epub 2013 Feb 21.

2.

Multimeric recombinant M2e protein-based ELISA: a significant improvement in differentiating avian influenza infected chickens from vaccinated ones.

Hadifar F, Ignjatovic J, Tarigan S, Indriani R, Ebrahimie E, Hasan NH, McWhorter A, Putland S, Ownagh A, Hemmatzadeh F.

PLoS One. 2014 Oct 16;9(10):e108420. doi: 10.1371/journal.pone.0108420. eCollection 2014.

3.

Field application of the H9M2e enzyme-linked immunosorbent assay for differentiation of H9N2 avian influenza virus-infected chickens from vaccinated chickens.

Kim MC, Choi JG, Kwon JS, Kang HM, Paek MR, Jeong OM, Kwon JH, Lee YJ.

Clin Vaccine Immunol. 2010 Dec;17(12):1977-84. doi: 10.1128/CVI.00191-10. Epub 2010 Oct 27.

4.
5.

Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T.

Avian Dis. 2007 Mar;51(1 Suppl):221-6.

PMID:
17494557
6.

Development and preliminary application of an indirect ELISA for detecting antibodies against Avian Influenza Virus.

Wang G, Ding J, Hu S, Yang X.

Res Vet Sci. 2012 Oct;93(2):710-5. doi: 10.1016/j.rvsc.2011.12.010. Epub 2012 Jan 9.

PMID:
22227012
7.

Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens.

Zhang X, Liu M, Liu C, Du J, Shi W, Sun E, Li H, Li J, Zhang Y.

Intervirology. 2011;54(5):290-9. doi: 10.1159/000319440. Epub 2011 Jan 13.

PMID:
21228535
8.

[Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].

Xu H, Wang YW, Tang YH, Zheng QS, Hou JB.

Bing Du Xue Bao. 2013 Jun;29(4):376-81. Chinese.

PMID:
23895000
9.
10.

Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.

Kim EH, Lee JH, Pascua PN, Song MS, Baek YH, Kwon HI, Park SJ, Lim GJ, Decano A, Chowdhury MY, Seo SK, Song MK, Kim CJ, Choi YK.

Virol J. 2013 Apr 3;10:104. doi: 10.1186/1743-422X-10-104.

11.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
12.

Development of a recombinant ELISA using yeast (Pichia pastoris)-expressed polypeptides for detection of antibodies against avian influenza A subtype H5.

Shehata AA, Fiebig P, Sultan H, Hafez M, Liebert UG.

J Virol Methods. 2012 Mar;180(1-2):18-25. doi: 10.1016/j.jviromet.2011.12.004. Epub 2011 Dec 14.

PMID:
22197190
13.

Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody.

He Q, Velumani S, Du Q, Lim CW, Ng FK, Donis R, Kwang J.

Clin Vaccine Immunol. 2007 May;14(5):617-23. Epub 2007 Mar 7.

15.

Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.

Kwon JS, Kim MC, Jeong OM, Kang HM, Song CS, Kwon JH, Lee YJ.

Vaccine. 2009 May 21;27(24):3189-94. doi: 10.1016/j.vaccine.2009.03.065. Epub 2009 Apr 10.

PMID:
19446190
16.

A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.

Velumani S, Ho HT, He F, Musthaq S, Prabakaran M, Kwang J.

PLoS One. 2011;6(6):e20737. doi: 10.1371/journal.pone.0020737. Epub 2011 Jun 10.

17.

An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.

Leung HC, Chan CC, Poon VK, Zhao HJ, Cheung CY, Ng F, Huang JD, Zheng BJ.

Emerg Microbes Infect. 2015 Apr;4(4):e22. doi: 10.1038/emi.2015.22. Epub 2015 Apr 8.

18.
19.

H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.

Lee DH, Park JK, Lee YN, Song JM, Kang SM, Lee JB, Park SY, Choi IS, Song CS.

Vaccine. 2011 May 23;29(23):4003-7. doi: 10.1016/j.vaccine.2011.03.067. Epub 2011 Apr 2.

PMID:
21463681
20.

Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens.

Upadhyay C, Ammayappan A, Vakharia VN.

Virol J. 2009 Oct 7;6:158. doi: 10.1186/1743-422X-6-158.

Supplemental Content

Support Center